Journal article
A. Tsoupras, R. Lordan, Katie Shiels, S. Saha, Constantina Nasopoulou, I. Zabetakis
Marine drugs, 2019
Marine drugs, 2019
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Tsoupras, A., Lordan, R., Shiels, K., Saha, S., Nasopoulou, C., & Zabetakis, I. (2019). In Vitro Antithrombotic Properties of Salmon (Salmo salar) Phospholipids in a Novel Food-Grade Extract. Marine Drugs.
Chicago/Turabian
Click to copy
Tsoupras, A., R. Lordan, Katie Shiels, S. Saha, Constantina Nasopoulou, and I. Zabetakis. “In Vitro Antithrombotic Properties of Salmon (Salmo Salar) Phospholipids in a Novel Food-Grade Extract.” Marine drugs (2019).
MLA
Click to copy
Tsoupras, A., et al. “In Vitro Antithrombotic Properties of Salmon (Salmo Salar) Phospholipids in a Novel Food-Grade Extract.” Marine Drugs, 2019.
BibTeX Click to copy
@article{a2019a,
title = {In Vitro Antithrombotic Properties of Salmon (Salmo salar) Phospholipids in a Novel Food-Grade Extract},
year = {2019},
journal = {Marine drugs},
author = {Tsoupras, A. and Lordan, R. and Shiels, Katie and Saha, S. and Nasopoulou, Constantina and Zabetakis, I.}
}
Abstract
Marine and salmon polar lipids (PLs) extracted by conventional extractions with non-food-grade solvents (CE-salmon-PLs) possess antithrombotic bioactivities against platelet-activating factor (PAF) and thrombin. Similar effects of food-grade-extracted (FGE) marine PLs have not yet been reported. In this study, food-grade solvents were used to extract PLs from Irish organic farmed salmon (Salmo salar) fillets (FGE-salmon-PLs), while their antithrombotic bioactivities were assessed in human platelets induced by platelet aggregation agonists (PAF/thrombin). FGE-salmon-PLs were further separated by thin layer chromatography (TLC) into lipid subclasses, and the antithrombotic bioactivities of each subclass were also assessed. LC-MS was utilized to elucidate the structure-activity relationships. FGE-salmon-PLs strongly inhibited PAF-induced platelet aggregation, while their relevant anti-thrombin effects were at least three times more potent than the previously reported activities of CE-salmon-PLs. TLC-derived lipid fractions corresponding to phosphatidylcholines (PC) and phosphatidylethanolamines (PE) were the most bioactive lipid subclasses obtained, especially against thrombin. Their LC-MS analysis elucidated that they are diacyl- or alkyl-acyl- PC and PE moieties baring ω3 polyunsaturated fatty acids (PUFA) at their sn-2 position, such as eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). Our results concerning the potent antithrombotic effects of FGE-salmon-PLs against both PAF and thrombin pathways strongly suggest that such food-grade extracts are putative candidates for the development of novel cardioprotective supplements and nutraceuticals.
